Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 114 (TMEM114) is a glycosylated transmembrane protein, highly conserved in vertebrates, and primarily expressed in the lens epithelium of the eye. It is associated with ocular development, with disruption or mutation linked to developmental eye disorders such as congenital cataract and microphthalmia. TMEM114 is structurally distinct from claudin family members and has homology to voltage dependent calcium channel gamma subunits but lacks some of their characteristic domains. Its expression at the plasma membrane is dependent on N-linked glycosylation. The precise cellular function is still under investigation, but it is considered essential for normal lens and eye formation. Key clarification: TMEM114 and Claudin-26 are not the same protein. Past database confusion is corrected by recent biochemical analyses; it is classified as a glycosylated transmembrane protein with significant roles in lens development, not a tight junction claudin nor an ion channel subunit.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 114 (TMEM114).